Lappe Mark bought INBX
September 8, 2026 · Form 4 insider transaction
Lappe Mark bought 500 shares of Inhibrx Biosciences, Inc. at $108.23 per share, a transaction worth $54.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Footnotes
The shares were purchased in multiple transactions at prices ranging from $108.05 to $108.66 inclusive. The reported price reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.; These securities are directly owned by the Lappe Family Trust. Mark P. Lappe is a trustee of the Lappe Family Trust and, in such capacity, may be deemed to indirectly beneficially own the securities owned by the Lappe Family Trust.